TABLE 3.
Distribution of GAS M types according to source of isolate
| M type | No. of isolates from the indicated sourcea:
|
||||||
|---|---|---|---|---|---|---|---|
| Invasive
|
Noninvasive
|
||||||
| NF | TSS | Meningitis | Bacteremic sepsis | Throat | Skin | Other mucosal sites | |
| 1 | 4 | 1 | 1 | 2 | 5 | 2 | 1 |
| 4 | 3 | 6 | 1 | ||||
| 12 | 1 | 5 | 4 | 7 | 5 | ||
| 22 | 1 | 1 | 1 | ||||
| 49 | 2 | 2 | 1 | ||||
| 53 | 4 | 1 | |||||
| 58 | 1 | 10 | |||||
| 77 | 1 | 2 | |||||
| Otherb | 3 | 1 | 2 | 7 | 18 | 1 | |
| Total | 7 | 2 | 2 | 13 | 21 | 52 | 10 |
a
NF, necrotizing fasciitis; TSS, toxic shock syndrome. Bacteremic sepsis includes skin and soft tissue infections (n = 4), pneumonia (n = 1), and primary bacteremia (n = 8).
b
Number of isolates for other M types: NF, 1 for M39, 1 for M95, and 1 for stHK; meningitis, 1 for M71; bacteremic sepsis, 1 for M11 and 1 for M81; throat, 1 for M8, 1 for M14, 1 for M18, 1 for M63, 1 for M75, 1 for M93, and 1 for M101; skin, 1 for M11, 2 for M25, 1 for M27, 1 for M28, 1 for M42, 1 for M64, 1 for M74, 1 for M75, 2 for M87, 1 for M89, 1 for M101, 2 for M102, 2 for M103, and 1 for M112; and other mucosal sites, 1 for M28.